{
  "retracted": false,
  "timestamp": 1577836800000,
  "updates": [
    {
      "timestamp": 1591690346565,
      "identifier": {
        "doi": "10.1016/j.ygyno.2019.10.020"
      },
      "type": "erratum"
    }
  ],
  "identifier": {
    "doi": "10.1016/j.ygyno.2018.11.036"
  },
  "journal": "Gynecologic Oncology",
  "publisher": "Elsevier BV",
  "title": "Corrigendum to ‘Chemotherapy and PARP inhibitors in heavily pretreated BRCA1/2 mutation ovarian cancer (BMOC) patients’ [Gynecologic Oncology 152 (2019) 270-277]"
}
